Kidney cancer remains to be an important item in the agenda of medicine. Better understanding of the mechanisms of renal cancer development, advances in surgery, utilization of alternative therapies and development of effective targeted therapies make kidney cancer a hot topic. The International Consultation on Urological Diseases (ICUD) and European Association of Urology (EAU) with the support of European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group organized the 2010 International Consultation on Kidney Cancer. Experts from all around the world gathered in Barcelona during the EAU Annual Meeting on April 16, 2010. Actually this was not a momentous event but a more than a year of planning and hard work of many people. Thanks to the hard work of everyone involved, only 11 months after the event, you are able to hold this excellent book and CD in your hand.
New developments on this disease makes it timely to have a presentation at the and a subsequent consensus report that finally will be presented as a booklet/CD-rom at the 2011 EAU meeting in Vienna.
Usually, when there are many developments in a field during a relatively short period of time, it is not easy to come to a consensus. In this respect, the chairmen of the 7 committees did a tremendous job to set the scene, to create the forum for discussing the relevant evidence and to finalize the elements of the consensus in their respective committees. While the committees went through a consensus process, they followed the Oxford grading system levels of evidence and used the four grades from the Oxford system for recommendations. This was done by a search for papers through the major databases covering the last years as Medline, Pubmed, Embase and Cochrane Library. They searched in relevant journals and evaluated all the papers.
The first committee chaired by Dr.Ljungberg (Umea, Sweden) investigated the ‘Etiology and epidemiology” of renal cell carcinoma (RCC). By describing the risk factors and incidence trends, they obtained the 2010 viewpoint and stated consensus. The second committee was on “Basic research in kidney cancer” and chaired by Dr Oosterwijk from Nijmegen were relevant research results were summarized. The following committee was dealing with “Pathology”and chaired by Dr.Algaba from Barcelona, Spain. An extensive description was given on morphology images and cytopathological entities with the latest classification issues described. Committee 4 gave one of most extensive overviews of “Prognostic factors” in renal cell carcinoma. Dr.Karakiewicz (Montreal, Canada) and his committee presented a literature-based overview reaching meta-analysis status. In committee 5, Dr.Van Poppel from Leuven, Belgium and the group gave one of the most detailed overviews of the current literature on “Treatment of localized RCC”. With the use of many illustrations it became one of the best publications on this subject so far. “Treatment of Locally advanced RCC’: was investigated by committee 6 under the chairmanship of Dr.Wood (Houston, USA). This subject was dealt with in a detailed manner and gave a valuable state-of-the-art on this very timely issue. Finally the “Treatment of Metastatic disease” was handled by committee 7 co-chaired by Dr.Bellmunt (Barcelona, Spain) and Dr. Patard (Rennes, France). In a time of rapid changes in the systemic management of RCC, they were able to implement the latest results in their consensus.
The ICUD/EAU 2010 International Consultation on Kidney Cancer is the first-time ever consensus meeting on one of the most hot topics in urologic oncology, Kidney Cancer. The chairmen and the experts in their respective committees have done a wonderful job to produce this state-of-the-art, evidence based knowledge and recommendations. We are grateful to the executive committees of ICUD and EAU respectively represented by Dr.Paul Abrams from Bristol, UK and Dr.Manfred Wirth from Dresden, Germany. Ms.Evelyn White and her team at EAU Central Office were extremely instrumental in logistics. Last but not least, this book could not be realized without the tireless work of Dr.Saad Khoury and his team.
We hope that you will enjoy reading this timely, up-to-date, evidence-based book and find the recommendations of the world-renown experts in kidney cancer useful in your practice.
Reproduction of documents, whole or in part, will need permission from the authors.